View allAll Photos Tagged biobots

Best seen large.

Find me uncensored on:

www.patreon.com/BrechtCorbeel

 

Follow Me on Medium For articles on various topics:

medium.com/@brechtcorbeel

 

Writing a book here: open.spotify.com/show/3mMrq70ofFvPputOjQIiGU?si=kwclM6f8Q...

 

www.brechtcorbeel.com/

www.google.com/search?q=brecht+corbeel

 

Free images:

unsplash.com/@brechtcorbeel

 

Follow me on:

www.instagram.com/brechtcorbeel/

twitter.com/BrechtCorbeel

www.artstation.com/brechtcorbeel

www.flickr.com/photos/brechtcorbeel/

www.facebook.com/brecht.corbeel

www.facebook.com/BCorbeel/

www.pinterest.com/bcorbeel/pins

www.linkedin.com/in/brecht-corbeel-a81b82184/

 

#visionary #illustration #2danimation #digitalpainting #conceptart #characterdesign #visualdevelopment #conceptdesign #characterartist #photoshop #environmentdesign #story #storytelling #movie #gaming #industry #Photo #Photography #work #talk #3d #cg #blender #brechtcorbeel #psyberspace #psyberverse #Xrystal #Aescermonium #rapthraeXeum #Xomplex #Xaethreal #Xrapthreum #AESTHETIOPIUM

Nita Madhav

Head of Epidemiology & Global Risk Analytics, Ginkgo Bioworks

 

Mariana Matus

CEO and Co-Founder, Biobot Analytics

 

Robert Nelsen

Co-Founder and Managing Director, Arch Venture Partners

 

Raj Panjabi

Special Assistant to the President and Senior Director for Global Health Security and Biodefense, National Security Council, The White House

 

Peter Sands

Executive Director, The Global

Fund to Fight AIDS, Tuberculosis and Malaria

 

Yong-Bee Lim

Deputy Director of The Converging Risks Lab, Council on Strategic Risks

A few people have commented that the previous motion series was a bit “sinister,” [1] so here I give you another rendering, where I was completely oblivious to the surrounding even now I am logically aware of my intention…

 

There are still a few of these which I haven’t gotten the time to work on but thanks to my data serialisation methodology I can still find it in my 100,000+ RAW Lightroom catalog…

 

# Notes

1. SML in Motion / SML Me (See-ming Lee 李思明) / SML.20130723.6D.21600.L1: www.flickr.com/photos/seeminglee/9366030820/

 

# Technical (Strobist) Info

+ Canon 580EX mounted on 6D set to manual 1/128 power and strobe at 10Hz.

+ Canon 430EX with umbrella on left hand side to slave and multi strobe with the 580EX.

+ Canon EOS 6D with EF 70-200 f/4L interval shooting with the Canon TC-80N3 remote.

 

# SML Data

+ Date: 2013-07-23T17:22:32+0800

+ Dimensions: 5472 x 3648

+ Exposure: 1.0 sec at f/7.1

+ Focal Length: 104 mm

+ ISO: 400

+ Flash: Canon 580EX + Canon 430EX

+ Camera: Canon EOS 6D

+ Lens: Canon EF 70-200 f/4L USM

+ Accessories: Canon 580EX (hotshoe) + Canon 430EX (umbrella) + Canon TC-80N3 + Manfrotto tripods

+ GPS: 22°25'10" N 114°13'26" E

+ Location: SML Universe HKG

+ Workflow: Lightroom 5

+ Serial: SML.20130723.6D.21584.L1

+ Series: SML Me, SML Labs

 

# Media Licensing

Creative Commons (CCBY) See-ming Lee 李思明 / SML Photography / SML Universe Limited

 

What I never see… / SML in Motion / SML Me (See-ming Lee 李思明) / SML.20130723.6D.21584.L1

 

www.flickr.com/photos/seeminglee/9642502459/

www.flickr.com/photos/seeminglee/9642502459/sizes/o/ (5472 x 3648)

SML’s obsession with G continues.

    

G says that he likes the rendering. He is now using it as his Facebook profile photo. But SML feels that particular rendering is not really a reflection of who G is.

    

SML asked if G has a choice, which colors would those be. G said he likes black, white, and blue. SML asked which kinds of blue? G said gray blue. SML observed that G likes Olek, and Olek has a lot of camouflaged crochet species. So SML picked a range of gray blues which would appear like camouflaged.

    

G said that he wanted to turn these into a Tshirt for himself. So SML picked three Pantone swatches blue black to make silkscreening easy. Also by request, designator switched to GWTF — which stands for Generation WTF, an awesome group on Facebook about everything awesome and sweet.

    

The Pantone specs are:

+ GWTF Light Blue: Pantone 628 C

+ GWTF Blue: Pantone 7702 C

+ GWTF Dark Blue: 7700 C

+ GWTF Black: Pantone Process Black C

    

Typography:

+ Helvetica Black. Seems something neutral is good for now. Might switch to Berthold Akzidenz Grotesk later because SML prefers that it has more character, But Akzidenz does not have the weight needed and SML does not yet have the time to draw custom fonts for G yet.

    

“Blue Camouflaged Anonymous GWTF” / SML.20130214.Design

/ #GWTF #DollazNsense #CCBY #SMLUniverse #SMLProjects #SMLMen #Crazyisgood #SMLFacebook

/ #G #GenWTF #GenerationWTF #GWTF #crazy #awesome #people #SMLLove #men #humans #biobots #identity #tshirts #design #illustration #typography #logo #Helvetica #camouflage #obsession #WTF

    

Nita Madhav

Head of Epidemiology & Global Risk Analytics, Ginkgo Bioworks

 

Mariana Matus

CEO and Co-Founder, Biobot Analytics

 

Robert Nelsen

Co-Founder and Managing Director, Arch Venture Partners

 

Raj Panjabi

Special Assistant to the President and Senior Director for Global Health Security and Biodefense, National Security Council, The White House

 

Peter Sands

Executive Director, The Global

Fund to Fight AIDS, Tuberculosis and Malaria

 

Yong-Bee Lim

Deputy Director of The Converging Risks Lab, Council on Strategic Risks

Nita Madhav

Head of Epidemiology & Global Risk Analytics, Ginkgo Bioworks

 

Mariana Matus

CEO and Co-Founder, Biobot Analytics

Testing the new Flickr iPhone / iPad app "Flick Stackr" with this texture edit. Thanks to Brenda Starr

Slush 2016

 

November 30th - December 1st

 

Helsinki, Finland

 

Photo: Kai Kuusisto

 

www.kaikuusisto.com

Nita Madhav

Head of Epidemiology & Global Risk Analytics, Ginkgo Bioworks

 

Mariana Matus

CEO and Co-Founder, Biobot Analytics

 

Robert Nelsen

Co-Founder and Managing Director, Arch Venture Partners

Nita Madhav

Head of Epidemiology & Global Risk Analytics, Ginkgo Bioworks

 

Mariana Matus

CEO and Co-Founder, Biobot Analytics

 

Robert Nelsen

Co-Founder and Managing Director, Arch Venture Partners

 

Raj Panjabi

Special Assistant to the President and Senior Director for Global Health Security and Biodefense, National Security Council, The White House

 

Nita Madhav

Head of Epidemiology & Global Risk Analytics, Ginkgo Bioworks

 

Mariana Matus

CEO and Co-Founder, Biobot Analytics

 

Robert Nelsen

Co-Founder and Managing Director, Arch Venture Partners

 

Raj Panjabi

Special Assistant to the President and Senior Director for Global Health Security and Biodefense, National Security Council, The White House

 

Peter Sands

Executive Director, The Global

Fund to Fight AIDS, Tuberculosis and Malaria

 

Yong-Bee Lim

Deputy Director of The Converging Risks Lab, Council on Strategic Risks

Nita Madhav

Head of Epidemiology & Global Risk Analytics, Ginkgo Bioworks

 

Mariana Matus

CEO and Co-Founder, Biobot Analytics

 

Robert Nelsen

Co-Founder and Managing Director, Arch Venture Partners

 

Raj Panjabi

Special Assistant to the President and Senior Director for Global Health Security and Biodefense, National Security Council, The White House

 

Peter Sands

Executive Director, The Global

Fund to Fight AIDS, Tuberculosis and Malaria

 

Yong-Bee Lim

Deputy Director of The Converging Risks Lab, Council on Strategic Risks

Nita Madhav

Head of Epidemiology & Global Risk Analytics, Ginkgo Bioworks

 

Mariana Matus

CEO and Co-Founder, Biobot Analytics

 

Robert Nelsen

Co-Founder and Managing Director, Arch Venture Partners

 

Raj Panjabi

Special Assistant to the President and Senior Director for Global Health Security and Biodefense, National Security Council, The White House

 

Peter Sands

Executive Director, The Global

Fund to Fight AIDS, Tuberculosis and Malaria

 

Yong-Bee Lim

Deputy Director of The Converging Risks Lab, Council on Strategic Risks

Slush 2016

 

November 30th - December 1st

 

Helsinki, Finland

 

Photo: Kai Kuusisto

 

www.kaikuusisto.com

Nita Madhav

Head of Epidemiology & Global Risk Analytics, Ginkgo Bioworks

 

Mariana Matus

CEO and Co-Founder, Biobot Analytics

Slush 2016

 

November 30th - December 1st

 

Helsinki, Finland

 

Photo: Kai Kuusisto

 

www.kaikuusisto.com

Slush 2016

 

November 30th - December 1st

 

Helsinki, Finland

 

Photo: Kai Kuusisto

 

www.kaikuusisto.com

Slush 2016

 

November 30th - December 1st

 

Helsinki, Finland

 

Photo: Kai Kuusisto

 

www.kaikuusisto.com

Slush 2016

 

November 30th - December 1st

 

Helsinki, Finland

 

Photo: Kai Kuusisto

 

www.kaikuusisto.com

Slush 2016

 

November 30th - December 1st

 

Helsinki, Finland

 

Photo: Kai Kuusisto

 

www.kaikuusisto.com

SML’s obsession with G continues with this typographic rendering—mainly because SML couldn’t help but see that the letters WTF is written all over his face and the letter G is the perfect place for the breather opening…

    

Yellow is added to give a bit of contrast. Some kind of accent is needed I think… even though it was not what G wished for…

    

“GWTF Dollaz Nsense” / SML.20130216.Design

/ #G #GWTF #GenWTF #CCBY #SMLUniverse #SMLMen #Crazyisgood #SMLLove #SML8IT

/ #illustration #design #people #men #typography #Helvetica #typeimage #WTF #LOL #obsession #biobots

Slush 2016

 

November 30th - December 1st

 

Helsinki, Finland

 

Photo: Kai Kuusisto

 

www.kaikuusisto.com

Genéricos presentando el tema "Biobots"...

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

www.reuters.com/world/uk/britain-offer-further-covid-19-b...

 

Britain to offer further COVID-19 boosters to elderly and immunosuppressed

Reuters

 

www.cnbc.com/2022/02/21/covid-uk-to-roll-out-additional-v...

 

UK to roll out additional Covid vaccine shot for over 75s and vulnerable people within weeks

 

Key Points

 

» The U.K. will roll out an additional Covid vaccine shot for the elderly and its clinically vulnerable population.

» From the spring, eligible individuals can get an additional shot provided 6 months have passed since their most recent dose.

» The announcement came as U.K. Prime Minister Boris Johnson prepares to announce an end to all remaining Covid-19 restrictions in England.

 

The U.K. will roll out an additional Covid vaccine shot for the elderly and its clinically vulnerable population, the country’s vaccines regulator announced on Monday.

 

Adults over the age of 75, nursing home residents and immunosuppressed over-12s will be given an extra dose of a Covid vaccine in the spring as a “precautionary strategy for 2022,” Britain’s Joint Committee on Vaccination and Immunisation said in a press release.

 

Over-18s will be offered the Pfizer-BioNTech or the Moderna Covid vaccine for their spring dose, while 12 to 18-year-olds will be given the Pfizer-BioNTech vaccine only.

 

An extra booster shot will be given 6 months after an eligible individual’s most recent dose, the JCVI said.

 

For older people in the U.K., this will be the fourth vaccine dose they have been offered. For people with a severely weakened immune system, it will be the fifth vaccine shot they have been offered. The bulk of the population has been offered three shots, two vaccinations and one booster.

 

The regulatory body noted in the release on Monday that “there remains considerable uncertainty with regards to the likelihood, timing and severity of any potential future wave of Covid-19 in the U.K.”

 

“There may be a transition period of a few years before a stable pattern, such as a regular seasonal wave of infection, is established,” the JCVI said.

 

Many of the U.K.’s oldest, and most vulnerable, adults received their most recent Covid vaccine in September or October. The JCVI noted that the immunity this group gained through their booster shot may wane substantially before the fall, when it plans to roll out a wider booster program.

 

Details on the fall program have not yet been publicized.

 

Of the eligible population in the U.K. — those aged 12 and over — 85% have been fully immunized with two doses of a Covid vaccine, and two-thirds have received a booster shot.

 

The JCVI’s announcement came as U.K. Prime Minister Boris Johnson prepares to announce an end to all remaining Covid restrictions in England, a move which has faced heavy criticism from medical professionals.

 

www.arkansasonline.com/news/2022/feb/21/cdc-virus-data-no...

 

CDC virus data not seen by public; agency says it’s not ready, cites fear of misinterpretation

 

For more than a year, the Centers for Disease Control and Prevention has collected data on covid-19 hospitalizations in the United States and broken it down by age, race and vaccination status. But it has not made most of the information public.

 

When the CDC published the first significant data two weeks ago on the effectiveness of boosters in adults younger than 65, it left out the numbers for a huge portion of that population: 18- to 49-year-olds, the group that the data showed was least likely to benefit from extra shots because the first two doses already left them well-protected.

 

The agency recently debuted a dashboard of wastewater data on its website that will be updated daily and might provide early signals of an oncoming surge of covid-19 cases. Some states and localities had been sharing wastewater information with the agency since the start of the pandemic, but it had never before released those findings.

 

Two years into the pandemic, the agency leading the country's response to the public health emergency has published only a tiny fraction of the data it has collected, several people familiar with the data said.

 

Much of the withheld information could help state and local health officials better target their efforts to bring the virus under control.

 

Detailed, timely data on hospitalizations by age and race would help health officials identify and help the populations at highest risk. Information on hospitalizations and deaths by age and vaccination status would have helped inform whether healthy adults needed booster shots.

 

And wastewater surveillance across the nation could spot outbreaks and emerging variants early.

 

Without the booster data for 18- to 49-year-olds, the outside experts whom federal health agencies look to for advice had to rely on numbers from Israel to make their recommendations on the shots.

 

Kristen Nordlund, a spokesperson for the CDC, said the agency has been slow to release data "because basically, at the end of the day, it's not yet ready for prime time." She said the agency's "priority when gathering any data is to ensure that it's accurate and actionable."

 

Another reason is fear that the information might be misinterpreted, Nordlund said.

 

Dr. Daniel Jernigan, the agency's deputy director for public health science and surveillance, said the pandemic exposed the fact that systems at the CDC, and at the state level, are outmoded and not up to handling large volumes of data. CDC scientists are trying to modernize the systems, he said.

 

"We want better, faster data that can lead to decision-making and actions at all levels of public health, that can help us eliminate the lag in data that has held us back," he added.

 

The CDC also has multiple bureaucratic divisions that must sign off on important publications, and its officials must alert the Department of Health and Human Services -- which oversees the agency -- and the White House of their plans. The agency often shares data with states and partners before making it public. Those steps can add delays.

 

"The CDC is a political organization as much as it is a public health organization," said Samuel Scarpino, managing director of pathogen surveillance at the Rockefeller Foundation's Pandemic Prevention Institute. "The steps that it takes to get something like this released are often well outside of the control of many of the scientists that work at the CDC."

 

FACING CRITICISM

 

The performance of vaccines and boosters, particularly in younger adults, is among the most noticeable omissions in data the CDC has made public.

 

Last year, the agency repeatedly came under fire for not tracking breakthrough infections in vaccinated Americans, focusing only on individuals who became ill enough to be hospitalized or die. The agency presented that information as risk comparisons with unvaccinated adults, rather than providing timely snapshots of hospitalized patients stratified by age, sex, race and vaccination status.

 

But the CDC has been routinely collecting information since the covid-19 vaccines were rolled out last year, according to a federal official familiar with the effort. The agency has been reluctant to make those figures public, the official said, because they might be misinterpreted as the vaccines being ineffective.

 

Nordlund confirmed that as one of the reasons. Another reason, she said, is that the data represents only 10% of the population of the U.S., although the CDC has relied on the same level of sampling to track influenza for years.

 

Some outside public health experts were stunned to hear that information exists.

 

"We have been begging for that sort of granularity of data for two years," said Jessica Malaty Rivera, a public health researcher and part of the team that ran the COVID Tracking Project, an independent effort that compiled data on the pandemic until March 2021.

 

A detailed analysis, she said, "builds public trust, and it paints a much clearer picture of what's actually going on."

 

Concern about the misinterpretation of hospitalization data broken down by vaccination status is not unique to the CDC. On Thursday, public health officials in Scotland said they would stop releasing data on hospitalizations and deaths by vaccination status because of similar fears that the figures would be misrepresented by anti-vaccine groups.

 

But the experts dismissed the potential misuse or misinterpretation of data as an acceptable reason for not releasing it.

 

"We are at a much greater risk of misinterpreting the data with data vacuums, than sharing the data with proper science, communication and caveats," Rivera said.

 

When the delta variant caused an outbreak in Massachusetts last summer, the fact that three-quarters of those infected were vaccinated led people to mistakenly conclude that the vaccines were powerless against the virus. But experts say that could have been avoided if the agency had educated the public from the start that as more people were vaccinated, the percentage of vaccinated people who were infected or hospitalized would also rise.

 

"Tell the truth, present the data," said Dr. Paul Offit, a vaccine expert and adviser to the Food and Drug Administration. "I have to believe that there is a way to explain these things so people can understand it."

 

Knowing which groups of people were being hospitalized in the U.S., which other conditions those patients may have had and how vaccines changed the picture over time would have been invaluable, Offit said.

 

Relying on Israeli data to make booster recommendations for Americans was less than ideal, Offit said. Israel defines severe disease differently than the U.S., among other factors.

 

DATA ON KIDS

 

It has also been difficult to find CDC data on the proportion of children hospitalized for covid-19 who have other medical conditions, said Dr. Yvonne Maldonado, chair of the American Academy of Pediatrics' Committee on Infectious Diseases.

 

The academy's staffers asked their partners at the CDC for that information on a call in December, according to a spokesperson for the group, and they were told it was unavailable.

 

Nordlund pointed to data on the agency's website that includes this information, and to multiple published reports on pediatric hospitalizations with information on children who have other health conditions.

 

Experts in wastewater analysis were more understanding of the CDC's slow pace of making that data public. The CDC has been building the wastewater system since September 2020 and increasing the capacity to present the data over the past few months, Nordlund said. In the meantime, the CDC's state partners have had access to the data, she said.

 

Despite the cautious preparation, the CDC released the wastewater data a week later than planned. The COVID Data Tracker is updated only on Thursdays, and the day before the original release date, the scientists who manage the tracker realized they needed more time to integrate the information.

 

"It wasn't because the data wasn't ready; it was because the systems and how it physically displayed on the page wasn't working the way that they wanted it to," Nordlund said.

 

The CDC has received more than $1 billion to modernize its systems, which may help pick up the pace, Nordlund said. “We’re working on that,” she said.

 

The agency’s public dashboard now has data from 31 states. Eight of those states, including Utah, began sending their figures to the CDC in the fall of 2020. Some relied on scientists volunteering their expertise; others paid private companies. But many others, such as Mississippi, New Mexico and North Dakota, have yet to begin tracking wastewater.

 

Utah’s fledgling program in April 2020 has now grown to cover 88% of the state’s population, with samples being collected twice a week, according to Nathan LaCross, who manages Utah’s wastewater surveillance program.

 

Wastewater data reflects the presence of the virus in an entire community, so it is not plagued by the privacy concerns attached to medical information that would normally complicate data release, experts said.

 

“There are a bunch of very important and substantive legal and ethical challenges that don’t exist for wastewater data,” Scarpino said. “That lowered bar should certainly mean that data could flow faster.”

 

Tracking wastewater can help identify areas experiencing a high burden of cases early, LaCross said. That allows officials to better allocate resources like mobile testing teams and testing sites.

 

Wastewater is also a much faster and more reliable barometer of the spread of the virus than the number of cases or positive tests. Well before the nation became aware of the delta variant, for example, scientists who track wastewater had seen its rise and alerted the CDC, Scarpino said. They did so in early May, just before the agency famously said vaccinated people could take off their masks.

 

Even now, the agency is relying on a technique that captures the amount of virus, but not the different variants in the mix, said Mariana Matus, CEO of BioBot Analytics, which specializes in wastewater analysis. That will make it difficult for the agency to spot and respond to outbreaks of new variants in a timely manner, she said.

 

“It gets really exhausting when you see the private sector working faster than the premier public health agency of the world,” Rivera said.

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

The Fischer design appears to have some merits. From the top-down view, it's easier to spot the bishops vs the pawns!

 

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

Biobot uses biotech and software developments to create an artistic narrative about the bio-technological body and its representation. The project is focused on tissue engineering and the harvesting of an electric signal from neurons which influences the movement and shape of a biobot.

 

Photo: Zoran Srdić Janežič

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

sympathetic frequencies

a poly embryonic ninja biobot production

 

Staring

Carol-Anne Day as Rebecca

Brendan Hunter as Toby

Peter Ellingson as Darren

 

Also

Jeff Furgala as Construction Worker

Andy Jackson as security

  

Director/Editor Spencer Estabrooks

Assistant Director Danielle White

DOP Matt Eakin

Camera Matt James

Gaffer/Grip Alex Free

Sound Design Carson Kadatz

Boom Op/Science Advisor Chad Hogan

Special Effects Mitch Barany

Stills/Cover Design Leigh Anthony Dehaney

No idea, new model, new paints, new brushes and a few hours. This is the result.

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

The project is focused on tissue engineering and the harvesting of an electric signal from neurons which influences the movement and shape of a biobot. The artistic and expert team grows neurons on an array with electrodes that conduct the electric signal. Through a complex sensing and programming system, the signal is converted from analogue to digital, amplified and used to move the biobot. Artificial intelligence compares the input from neurons with the movements of different arthropods and selects the appropriate number of legs and joints. The result is an unpredictable zoomorphic form. Biobot brings new biotechnological and algorithmic processes to artistic practices. It uses biotech and software developments to create an artistic narrative about the bio-technological body and its representation. The algorithmic search for the shape in relation to biological data becomes an evolutionary process. The biobot aspires to be a living entity with its own intelligence and movement.

 

Photo: Florian Voggeneder

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

We were so excited to be back in Philadelphia where we hosted a mixer & startup showcase at CityCoho. We had many of the city's hottest startups showcase and two of them had a chance to attend Tech Cocktail's Celebrate Conference earlier in the week. Here were the showcasing startups:

 

Pico

Beacon & Lively

BioBots

Colabination

NarrativeDX

Livegenic

Smack Innovations

MEG.com

Instamour Inc.

Eventousity

Vimty

FanCheer Interactive, Inc

Nftoshare

 

Congrats to Pico for winning Reader's Choice and Beacon & Lively for winning the Online Poll!

 

Photographer Credit: SJH Foto

1 3 4 5 6 7 8